485 related articles for article (PubMed ID: 34023019)
1. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.
Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU
Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019
[TBL] [Abstract][Full Text] [Related]
2. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
[TBL] [Abstract][Full Text] [Related]
3. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C
Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.
Bighelli I; Rodolico A; García-Mieres H; Pitschel-Walz G; Hansen WP; Schneider-Thoma J; Siafis S; Wu H; Wang D; Salanti G; Furukawa TA; Barbui C; Leucht S
Lancet Psychiatry; 2021 Nov; 8(11):969-980. PubMed ID: 34653393
[TBL] [Abstract][Full Text] [Related]
6. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
Huhn M; Nikolakopoulou A; Schneider-Thoma J; Krause M; Samara M; Peter N; Arndt T; Bäckers L; Rothe P; Cipriani A; Davis J; Salanti G; Leucht S
Lancet; 2019 Sep; 394(10202):939-951. PubMed ID: 31303314
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-acting injectable
Vita G; Tavella A; Ostuzzi G; Tedeschi F; De Prisco M; Segarra R; Solmi M; Barbui C; Correll CU
Ther Adv Psychopharmacol; 2024; 14():20451253241257062. PubMed ID: 38831918
[TBL] [Abstract][Full Text] [Related]
10. Modafinil for people with schizophrenia or related disorders.
Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines for schizophrenia.
Volz A; Khorsand V; Gillies D; Leucht S
Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
[TBL] [Abstract][Full Text] [Related]
12. New generation antipsychotics for first episode schizophrenia.
Rummel C; Hamann J; Kissling W; Leucht S
Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
[TBL] [Abstract][Full Text] [Related]
13. Risperidone dose for schizophrenia.
Li C; Xia J; Wang J
Cochrane Database Syst Rev; 2009 Oct; (4):CD007474. PubMed ID: 19821422
[TBL] [Abstract][Full Text] [Related]
14. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
15. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
16. Maintenance treatment with antipsychotic drugs for schizophrenia.
Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
[TBL] [Abstract][Full Text] [Related]
17. Perazine for schizophrenia.
Leucht S; Hartung B
Cochrane Database Syst Rev; 2006 Apr; (2):CD002832. PubMed ID: 16625562
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole for schizophrenia.
El-Sayeh HG; Morganti C
Cochrane Database Syst Rev; 2006 Apr; (2):CD004578. PubMed ID: 16625607
[TBL] [Abstract][Full Text] [Related]
19. Adverse events after antipsychotic discontinuation: an individual participant data meta-analysis.
Brandt L; Schneider-Thoma J; Siafis S; Efthimiou O; Bermpohl F; Loncar L; Neumann K; Hasan A; Heinz A; Leucht S; Gutwinski S
Lancet Psychiatry; 2022 Mar; 9(3):232-242. PubMed ID: 35183280
[TBL] [Abstract][Full Text] [Related]
20. Risperidone versus typical antipsychotic medication for schizophrenia.
Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
